As the global economy mends, the 2021 growth of Ammoniated Glycyrrhizin(CAS 53956-04-0) will have significant change from previous year. According to our (LP Information) latest study, the global Ammoniated Glycyrrhizin(CAS 53956-04-0) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Ammoniated Glycyrrhizin(CAS 53956-04-0) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Ammoniated Glycyrrhizin(CAS 53956-04-0) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ammoniated Glycyrrhizin(CAS 53956-04-0) market, reaching US$ million by the year 2028. As for the Europe Ammoniated Glycyrrhizin(CAS 53956-04-0) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ammoniated Glycyrrhizin(CAS 53956-04-0) players cover Ruihong Bio-technique, ELION Group, Hunan Dinuo Pharmaceutical, and Minophagen Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ammoniated Glycyrrhizin(CAS 53956-04-0) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Food Grade Ammoniated Glycyrrhizin
Feed Grade Ammoniated Glycyrrhizin
Pharmaceuticals Grade Ammoniated Glycyrrhizin
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Food & Beverages
Cosmetics
Pharmaceuticals
Animal and Pet Products
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Ruihong Bio-technique
ELION Group
Hunan Dinuo Pharmaceutical
Minophagen Pharmaceutical
Xinjiang TIANSHAN Pharmaceuticals Industry
Alps Pharmaceutical
Xinjiang Kunlunshengnong
Tiansheng Pharmaceutical
Shaanxi Fujie Pharmaceutical
FAME Pharmaceuticals Industry
MAFCO Worldwide
Fanzhi Group
Gansu Yalan Pharmaceutical
Greenline Biotech
Qingdao Taitong Pharmaceutical
Cokey
Lion Corporation